Status:
COMPLETED
Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers
Lead Sponsor:
Changhai Hospital
Conditions:
Obesity
Overweight
Eligibility:
All Genders
18-25 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine whether calcium plus vitamin D supplementation is conducive to weight and fat loss during energy restriction in very-low calcium consumers.
Detailed Description
Due to the contradicting findings in the hypothesis of calcium supplementation on weight and fat loss, which might be explained by the difference in initial calcium intake, the present study is aimed ...
Eligibility Criteria
Inclusion
- Male or female 18 to 25 years of age, generally healthy
- Habitual calcium intake below 600mg/d
- Overweight or obese (BMI between 24 and 35kg/m2, refer to the Chinese standard)
- Stable body weight (body weight change less than 1kg two months before screening)
- Less than 3 times of 20min of physical exercise per week
- Signed written informed consent
Exclusion
- Coronary heart disease, hypertension, diabetes; hepatic insufficiency or renal insufficiency, hyper- or hypothyroidism, mal-absorption, cholesterol concentrations requiring pharmaceutical treatment
- Pregnant or lactating woman
- Use of calcium supplements, oral antidiabetic agents, antihyperlipidemics or any other medications affecting metabolism 30 days before randomization
- Participating in another weight loss programs (i.e. taking oral pharmacotherapeutic agents and/or herbal preparations intended for the management of obesity; excessive physical activity; be on a diet)
- On special diets (i.e. vegetarian)
- Presently taking or have recently taken a prescription drug such as fluoroquinolone antibiotics, tetracycline, or levothyroxine (thyroid medication)
- Participating in another clinical trial 6 months before randomization
- Unlikely to be compliant (i.e. alcohol, drug abuse)
- Refusal or inability to give informed consent to participate in the study
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01447433
Start Date
April 1 2011
End Date
February 1 2012
Last Update
August 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, China, 200433